Výsledky vyhledávání - "Pilar Caro-Mateo"

Intracoronary tenecteplase versus abciximab as adjunctive treatment during primary percutaneous coronary intervention in patients with anterior myocardial infarction

Autor: Pablo J. González-Pérez, Juan C Rodriguez-Yanez, Pedro Martínez-Romero, Pilar Caro-Mateo, Ana M Serrador-Frutos, Francisco J. Morales-Ponce, Isabel Diaz-Torres, Juan A. Sánchez-Brotons, Francisco J Lozano-Cid

Publikováno v: EuroIntervention. 14:1668-1675

Aims We sought to compare the effects of intracoronary administration of a fibrinolytic drug (tenecteplase) to those of a glycoprotein IIb/IIIa inhibitor (abciximab) in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48348582425198997e4d041f86689280
https://doi.org/10.4244/eij-d-18-00885

Zobrazit plný text záznamu

Effects of intracoronary antithrombotics on ventricular function: A comparison of tenecteplase versus abciximab during primary percutaneous intervention in myocardial infarction

Autor: Pedro Martínez-Romero, Sara Blasco-Turrión, Eduardo Martínez-Morentín, Carmen Collado-Moreno, Pilar Caro-Mateo, Francisco J. Morales-Ponce, Juan Antonio Sánchez-Brotons, Pablo J. González-Pérez

Publikováno v: Cardiology Journal 2021, Vol. 28, No. 1, 176–178
RODIN: Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Universidad de Cádiz
Cardiol J
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
instname

Adjunctive medical therapy during primary percutaneous coronary intervention (PPCI) is based on anticoagulation and antiplatelet drugs. Additionally, the glycoprotein IIb/IIIa inhibitor (GPI) abciximab has been shown to reduce infarct size in some cl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cfad1a55be4396b2a2929ff9969d6ae
http://hdl.handle.net/10498/24794

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání